Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-drug Interaction Between Tacrolimus and Mycophenolate Mofetil
NCT02743247Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2015
- Primary completion
- Apr 2016
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tacrolimus and mycophenolate mofetil in graft rejection, sponsored by Seoul National University Hospital. Primary endpoint: Area under the concentration versus time curve at 72 hours. Started Oct 2015; status: completed.
02
Drugs
tacrolimusmycophenolate mofetil
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT02743247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02743247.